DOI: 10.4244/EIJV10I2A44

Two cases of thrombotic stenosis in SAPIEN XT valves after transapical implantation

Tina H. Leetmaa1*, MD; Steen H. Poulsen1, MD; Bjarne L. Nørgaard1, MD; Kaj-Erik Klaaborg2, MD; Kim Terp2, MD; Søren Høyer3, MD; Evald H. Christiansen1, MD; Henning R. Andersen1, MD

We report two cases of aortic valve stent thrombosis after uneventful transcatheter transapical aortic valve implantation of the 29 mm Edwards SAPIEN XT (Edwards Lifesciences, Irvine, CA, USA) in high-risk patients. Subcutaneous low molecular weight heparin 5,000 units daily for five days, aspirin 75 mg daily lifelong, and clopidogrel 75 mg daily for 12 months were given. After four weeks, antiplatelet therapy was reduced to monotherapy due to bleeding problems. Shortly after, the patients developed refractory heart failure and died on day 106 and on day 137, respectively. Transoesophageal echocardiography (Online Figure 1 and Moving image 1 and 2) and multislice computed tomography (Figure 1A and Figure 1B) showed signs of stent valve thrombosis.

The autopsy and histology showed that the valve leaflets were thickened, stiff and with fibrosis on both sides of the leaflets, which was more than three months old. Two layers of thrombosis were seen on top of the fibrosis (Figure 1C and Figure 1D). The most profound layer of thrombus was more than one month old, and the fresh thrombosis was very recent with the specific lines of Zahn. There were no signs of macro defects or endocarditis on the leaflets.

Figure 1. A) Multislice computed tomography image in case 1 showing the aortic stent prosthesis in the long-axis view in systole with thrombus (low attenuation mass, arrow) and fixation of the “right” leaflet. B) Multislice computed tomography image in case 1 showing the aortic stent prosthesis in short-axis view in systole with thrombus visualised as low attenuation masses (arrows) in relation to the “right” and “left” leaflet, respectively. C) Macroscopic image of the aortic valve stent. D) Masson trichrome stained section of a thrombosed leaflet: a) fresh thrombosis, b) recent thrombosis, c) fibrosis, d) native leaflet, and e) fibrosis.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Online data supplement

Online Figure 1. Transoesophageal echocardiography in case 1 showing the aortic stent prosthesis in the long-axis view with an immobile “right” valve leaflet (white arrow) whereas the “non-coronary” leaflet (red arrow) is well opened in systole.

Moving image 1. Transoesophageal echocardiogram in case 2 showing the aortic stent prosthesis in the two-dimensional longitudinal axis.

Moving image 2. The three-dimensional short-axis view with a thickened and immobile “right” valve leaflet.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Transoesophageal echocardiogram in case 2 showing the aortic stent prosthesis in the two-dimensional longitudinal axis.

Moving image 2. The three-dimensional short-axis view with a thickened and immobile "right" valve leaflet.

Volume 10 Number 2
Jun 20, 2014
Volume 10 Number 2
View full issue


Key metrics

Suggested by Cory

IMAGE IN CARDIOLOGY

10.4244/EIJV10I11A233 Mar 20, 2015
Pseudo early degeneration of a transcatheter aortic valve prosthesis due to thrombosis
de Brito Jr F et al
free

10.4244/EIJV7I1A28 May 17, 2011
Valve thrombosis after transcatheter heart valve implantation
Tay E et al
free

State-of-the-Art

10.4244/EIJ-D-25-00512 Mar 16, 2026
Transcatheter aortic valve thrombosis
Jacobsen M et al
free

10.4244/EIJV11SWA28 Sep 17, 2015
Antithrombotic therapy in TAVI patients: changing concepts
Gargiulo G et al
free

10.4244/EIJV15I7A102 Sep 20, 2019
Antithrombotic therapy after TAVI: where are we going?
Wilkins B et al
free

10.4244/EIJV9SSA9 Sep 15, 2013
Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?
Collet J and Montalescot G
free

AORTIC VALVE INTERVENTIONS

10.4244/EIJV12SYA7 Sep 18, 2016
Leaflet motion abnormality after TAVI: genuine threat or much ado about nothing?
Chakravarty T et al
free
Trending articles
334.8

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved